Showing results (1671-1680 of 1,728) with videos related to
Sort By:
Pageof 173
Blood|June 28, 2003
Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemiaAnthony V Moorman, Sue M Richards, Mary Martineau, et al.Biorxiv : the Preprint Server for Biology|April 10, 2026
Empagliflozin preserves cardiac function and modulates metabolism in a mouse model of Duchenne muscular dystrophyBenjamin J Zeidler, Connor Thomas, John P Salvas, et al.The Lancet. Oncology|February 7, 2017
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trialCorneel Coens, Stefan Suciu, Vanna Chiarion-Sileni, et al.The Journal of Chemical Physics|April 17, 2016
Synthesis of a mixed-valent tin nitride and considerations of its possible crystal structuresChristopher M Caskey, Aaron Holder, Sarah Shulda, et al.Blood|December 16, 2006
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V Moorman, Christine J Harrison, Georgina A N Buck, et al.Cancer Discovery|March 21, 2020
Tuning the Antigen Density Requirement for CAR T-cell ActivityRobbie G Majzner, Skyler P Rietberg, Elena Sotillo, et al.Molecular Cancer Therapeutics|August 11, 2021
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic CancerDandan Li, Nicholas Schaub, Theresa M Guerin, et al.Cancer Research|March 29, 2022
Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine TreatmentMarina Roy-Luzarraga, Louise E Reynolds, Beatriz de Luxán-Delgado, et al.Circulation Research|February 4, 2026
Leptin Activates Brain-BAT-Heart Crosstalk to Promote Cardiac ProtectionAna C M Omoto, Ivan Vechetti, Jussara M do Carmo, et al.Nature Medicine|April 15, 2026
Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypesChenyu Li, Shola M Richards, Ghazal Quinn, et al.Pageof 173